New Biomarker Identified for Breast, Prostate Cancers: A Vital Step Towards Cancer Research

Experts have identified a new genetic biomarker which could bolster efforts to better identify patients who respond to certain types of chemotherapy drugs.

Scientists from Cedars-Sinai Medical Centre in Los Angeles have identified a novel genetic biomarker responsible for the progression of many breast and prostate cancers.

The finding could bolster efforts to better identify patients who respond to certain types of chemotherapy drugs that attack the most aggressive forms of cancer.

Researchers Find New Biomarker for Detecting Early Stage Pancreatic Cancer
A combination of three proteins appears to be a good indicator of early stage pancreatic cancer when found in high levels in urine.

"Understanding and identifying biomarkers is a vital step toward cancer research and care," said lead study author Michael Freeman from Cedars-Sinai Medical Centre in Los Angeles, California, US.

"New profiling strategies exemplified by this study will ultimately improve our ability to treat cancer patients," Freeman noted.

The newly identified genetic biomarker - diaphanous- related formin-3 or DIAPH3 - participates in a protein interaction that makes cells rigid.

Biomarker In Blood Can Help Identify Young People For Binge Drinking
The biomarker called phosphatidylethanol (PEth), was found to be higher in people who are binge drinkers than those who drink moderately.

The study found that when this biomarker is lost or lowered, cells become "deformable," squeezing through tissue spaces, causing disease growth or progression.

The study was published in the journal Scientific Reports.

New Genomic Biomarker Detects Lung Cancer More Accurately in Suspected Patients
A genomic biomarker can accurately determine the likelihood of a lung lesion being malignant, which will allow physicians to confidently identify the patients.

Source-IANS

Minomic International Ltd. Develops New Biomarker to Detect Prostate Cancer
MiCheck™ technology using Glypican-1, a biomarker that detects prostate cancer will be introduced at the International Conference of Urology in New Orleans.

MEDINDIA

Search Medindia

New Biomarker Identified for Breast, Prostate Cancers: A Vital Step Towards Cancer Research

Experts have identified a new genetic biomarker which could bolster efforts to better identify patients who respond to certain types of chemotherapy drugs.